1. 1) Tashiro, F., Hirai, K., Ueno, Y.: Inhibitory effects of carcinogenic mycotoxins on deoxyribonucleic acid-dependent ribonucleic acid polymerase. Appl Environ Microbiol, 38, 191-196 (1979)
2. 2) Groopman, J.D., Jiaqi, Z., Donahue, P.R., Pikul, A., Lisheng, Z., Jun-shi, C., Wogan, G.N.: Molecular dosimetry of urinary aflatoxin-DNA adducts in people living Guangxi Autonomous Region, People’s Republic of China. Cancer Res, 52, 45-52 (1992)
3. 3) Stern, M.C., Umbach, D.M., Yu, M.C., London, S.J., Zhang, Z.Q., Taylor, J.A.: Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People’s Republic of China, and a meta-analysis of existing studies. Cancer Epdemiol Miomarkers Prev, 10, 617- 625 (2001)
4. 4) Tashiro, F., Morimura, S., Hayashi, K., Makino, R., Kawamura, H., Horikoshi, N., Nemoto, K., Ohtsubo, K., Sugimura T., Ueno, Y.: Expression of the c-Ha-ras and c-myc genes in aflatoxin B1-induced hepatocellular carcinomas. Biochem Biophys Res Commun, 138, 858-864 (1986)
5. 5) Morimura, S., Tashiro, F., Ueno, Y.: Establishment and characterization of cell lines (Kagura-1 and Kagura-2) from aflatoxin B1-induced rat hepatomas. Chem Pharm Bull, 38, 460-463 (1990)